PLRZ — Polyrizon Ltd.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1893645 · Israel
Last close
$16.07
Market Cap
$30.08M
52W High
$17.50
52W Low
$10.50
ADV30
50,814
Next earnings
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 21,437,000 1,306,000 443,000
Jun 2025 18,739,000 15,828,000 364,000
Dec 2024 5,547,000 2,554,000 261,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-8,401,000
Inventory
Receivables
ST Investments
$11,158,000
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -5,785,000 -3,335,000 21,437,000 443,000 -4,528,000
Dec 2024 0 -1,302,000 -1,545,000 5,547,000 261,000 -1,147,000
Dec 2023 0 -635,000 -600,000 559,000 750,000 -537,000
Dec 2022 0 -895,000 -779,000 546,000 1,446,000 -1,132,000

Peers — same industry

TickerNameMarket CapLastDaily %
PLSM Pulsenmore Ltd. $29.46M $4.53
CTSO Cytosorbents Corp $29.05M $0.46
IINN Inspira Technologies OXY B.H.N. Ltd $31.68M $0.73
MLSS MILESTONE SCIENTIFIC INC. $32.77M $0.37
CODX Co-Diagnostics, Inc. $33.32M $9.11

News headlines (Yahoo Finance, 1h cache)

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial
2026-05-13 13:25 · Yahoo
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
2026-05-04 12:45 · Yahoo
Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform
2026-04-27 13:28 · Yahoo
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
2026-04-08 20:16 · Yahoo
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement
2026-04-07 12:00 · Yahoo
Polyrizon Provides 2025 and Recent Highlights
2026-03-26 13:23 · Yahoo
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
2026-03-25 21:25 · Yahoo
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications
2026-03-24 12:47 · Yahoo
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program
2026-03-17 12:25 · Yahoo
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
2026-03-10 11:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.